BioMarin Pharmaceutical Inc. (LON:0HNC)
London · Delayed Price · Currency is GBP · Price in USD 58.99
-0.75 (-1.26%)
Jan 5, 2026, 7:02 PM GMT
BioMarin Pharmaceutical Market Cap
BioMarin Pharmaceutical has a market cap or net worth of 8.37 billion as of January 6, 2026. Its market cap has decreased by -16.95% in one year.
Market Cap
8.37B
Enterprise Value
7.72B
Revenue
2.30B
Ranking
n/a
PE Ratio
21.62
Stock Price
58.99
Market Cap Chart
Since July 23, 1999, BioMarin Pharmaceutical's market cap has increased from 283.77M to 8.37B, an increase of 2,849.24%. That is a compound annual growth rate of 13.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 5, 2026 | 8.37B | -1.34% |
| Dec 31, 2025 | 8.48B | -15.22% |
| Dec 31, 2024 | 10.01B | -29.83% |
| Dec 29, 2023 | 14.26B | -10.67% |
| Dec 30, 2022 | 15.96B | 33.26% |
| Dec 31, 2021 | 11.98B | 2.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.77B |
| GSK plc | 73.48B |
| Haleon | 32.96B |
| Smith & Nephew | 10.35B |
| Convatec Group | 4.67B |
| Hikma Pharmaceuticals | 3.37B |
| HUTCHMED (China) | 1.75B |
| Genus | 1.70B |